Mar 22 | Sep 21 | Mar 21 | Sep 20 | Mar 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ ― | $ 1.40M | $ ― | $ 2.12M | $ ― |
Total Assets | $ 80.14M | $ 70.99M | $ 61.61M | $ 63.48M | $ 60.91M |
Total Debt | $ ― | $ 26.05M | $ ― | $ 23.55M | $ ― |
Net Debt | $ ― | $ 24.65M | $ ― | $ 21.43M | $ ― |
Total Liabilities | $ 53.40M | $ 40.67M | $ 31.19M | $ 32.65M | $ 33.32M |
Stockholders Equity | $ 26.74M | $ 30.32M | $ 30.43M | $ 30.83M | $ 27.60M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |